Paul Thomen
Showing posts with label Dialysis. Show all posts
Showing posts with label Dialysis. Show all posts

Wednesday, 29 January 2014

Global Dialysis Market 2018



The report “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018″ by MarketsandMarkets is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018 in subject line and your contact details to purchase this report or get your questions answered.

The global dialysis market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global dialysis market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period. The hemodialysis (HD) products and services market includes machines, consumables, and services. The peritoneal dialysis (PD) products and services market includes concentrates/dialysates, cyclers, catheters, transfer sets, accessories, and PD services.
Moreover, the global dialysis market has also been classified on the basis of end users into in-center dialysis and home dialysis. The hemodialysis market is further segmented into center use HD and home HD. The peritoneal dialysis market is segmented into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy. The in-center dialysis end users market includes hospitals and independent dialysis centers; whereas, the home dialysis end users market includes peritoneal dialysis end users and home hemodialysis end users. Based on geography, the market is divided into North America, Asia-Pacific, Europe, and Rest of the World (RoW).

A number of factors such as the growing number of end stage renal disease patients and increasing prevalence of diabetes and hypertension are driving the growth of the dialysis market. In addition, factors such as low preference of patients for kidney transplantation, technological advancements, increase in private investment and venture funding to support the development of new products, and substantial government healthcare expenditure on the treatment of end-stage renal disease are further stimulating the growth of the dialysis products and services market. However, factors such as low awareness about kidney diseases and their treatment modalities (primarily in developing countries), reduction in Medicare reimbursements to dialysis centers, product recalls, and reuse of hemodialysis consumables (such as dialyzers and bloodlines) are restraining the growth of the dialysis market.
In 2013, North America holds the largest share in the global dialysis market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the dialysis market in the Asia-Pacific region.

The major players in the dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.).

Scope of the Report
This research report categorizes the global dialysis market into the following segments and sub-segments:

Global Hemodialysis Market, By Products and Services
  • Hemodialysis Services
  • In-center Hemodialysis services
  • Home Hemodialysis Services
  • Hemodialysis Products
  • Hemodialysis Machines
  • Center Use Hemodialysis Machines
  • Home Use Hemodialysis Machines
  • Hemodialysis Consumables/supplies
  • Dialyzers
  • Hemodialysis Access Products
  • Hemodialysis Bloodlines
  • Hemodialysis Concentrates/dialysates
  • Others
Global Peritoneal Dialysis Market, By Products and Services
  • Peritoneal Dialysis Products
  • Peritoneal Dialysis Concentrates/dialysates
  • Peritoneal Dialysis Machines
  • Peritoneal Dialysis Catheters
  • Peritoneal Dialysis Transfer Sets
  • Other
  • Peritoneal Dialysis Services
Global Dialysis Market, By Category
  • Hemodialysis
  • Center Use Hemodialysis
  • Home Hemodialysis
  • Peritoneal Dialysis
  • Continuous Cycling Peritoneal Dialysis (CCPD)
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Intermittent PD (IPD)
  • PD Plus Therapy
Global Dialysis Market, By End Users
  • In-center Dialysis
  • Hospitals
  • Independent Dialysis Centers
  • Home Dialysis
  • Peritoneal Dialysis
  • Home Hemodialysis
Global Dialysis Market, by Geography
  • North America
  • Asia-Pacific
  • Europe
  • RoW (Rest of the World)
Few Points from Table Of Content
Company Profiles
11.1 Asahi Kasei Medical Co., Ltd.
11.2 B. Braun Melsungen Ag
11.3 Baxter International, Inc.
11.4 Bellco S.R.L.
11.5 Covidien, Plc
11.6 Davita Healthcare Partners, Inc.
11.7 Diaverum Deutschland Gmbh
11.8 Fresenius Medical Care Ag & Co. Kgaa
11.9 Gambro Ab
11.10 Kawasumi Laboratories, Inc.
11.11 Medical Components, Inc.
11.12 Medionics International, Inc.
11.13 Nikkiso Co. Ltd.
11.14 Nipro Corporation
11.15 Nxstage Medical, Inc.
For further information on Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018” report OR for any other business research / market intelligence need on the ‘Medical Devices ’ market (http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .), contact sales@rnrmarketresearch.com / Call +1 888 391 5441.

Thursday, 14 November 2013

Dialysis Market - Hospital, Independent Dialysis Center, Home Dialysis to 2018



The report “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018” by MarketsandMarkets is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with report name in subject line and your contact details to purchase this report or get your questions answered.

The global dialysis market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global dialysis market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period. The hemodialysis (HD) products and services market includes machines, consumables, and services. The peritoneal dialysis (PD) products and services market includes concentrates/dialysates, cyclers, catheters, transfer sets, accessories, and PD services.

Moreover, the global dialysis market has also been classified on the basis of end users into in-center dialysis and home dialysis. The hemodialysis market is further segmented into center use HD and home HD. The peritoneal dialysis market is segmented into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy. The in-center dialysis end users market includes hospitals and independent dialysis centers; whereas, the home dialysis end users market includes peritoneal dialysis end users and home hemodialysis end users. Based on geography, the market is divided into North America, Asia-Pacific, Europe, and Rest of the World (RoW).


A number of factors such as the growing number of end stage renal disease patients and increasing prevalence of diabetes and hypertension are driving the growth of the dialysis market. In addition, factors such as low preference of patients for kidney transplantation, technological advancements, increase in private investment and venture funding to support the development of new products, and substantial government healthcare expenditure on the treatment of end-stage renal disease are further stimulating the growth of the dialysis products and services market. However, factors such as low awareness about kidney diseases and their treatment modalities (primarily in developing countries), reduction in Medicare reimbursements to dialysis centers, product recalls, and reuse of hemodialysis consumables (such as dialyzers and bloodlines) are restraining the growth of the dialysis market.

In 2013, North America holds the largest share in the global dialysis market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the dialysis market in the Asia-Pacific region.


The major players in the dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.).

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)
11.1 Asahi Kasei Medical Co., Ltd.
11.2 B. Braun Melsungen Ag
11.3 Baxter International, Inc.
11.4 Bellco S.R.L.
11.5 Covidien, Plc
11.6 Davita Healthcare Partners, Inc.
11.7 Diaverum Deutschland Gmbh
11.8 Fresenius Medical Care Ag & Co. Kgaa
11.9 Gambro Ab
11.10 Kawasumi Laboratories, Inc.
11.11 Medical Components, Inc.
11.12 Medionics International, Inc.
11.13 Nikkiso Co. Ltd.
11.14 Nipro Corporation
11.15 Nxstage Medical, Inc.


Browse more reports on Medical Devices Market @ http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .

Wednesday, 15 May 2013

Research and Development Prospect of China Dialysis Market, 2013-2017

RnRMarketResearch.com adds “Research and Development Prospect of China Dialysis Market, 2013-2017”new report on its database.

“Research and Development Prospect of China Dialysis Market, 2013-2017″ firstly conducts a profound analysis on the market status, policy environment, existing problems and favorable factors of China’s dialysis industry; this report also summarizes the latest development situation of international and domestic key enterprise, and finally launches a forecast for this industry’s future development, which can provide decision-making reference for the enterprises and investors.

In 2012, the scale of China’s dialysis market was about CNY 12 billion, of which, the scale of hemodialysis market and peritoneal dialysis was about CNY 10 billion and CNY 2 billion respectively. In China, hemodialysis has been very popular in China, and there are about 1,000 hospitals have carried out this treatment.


Fresenius in Germany, Nikkiso in Japan, Baxter in the United State, Cambro in Sweden, Asahi Kasei in Japan and some other foreign-funded enterprises lead the development of China’s dialysis market. The domestic enterprises mainly produce some low-tech products, such as dialysis circuit tube and dialyzate; rare domestic enterprises can produce dialyzer, dialysis machine and other high-end products. Among current domestic enterprises, Weigao is the leader in the field of hemodialysis machine and Huaren Pharmaceutical is the leader in the peritoneal dialysis field.


Table of Content

1. Overview of Dialysis Market
1.1 Definition
1.2 Classification
1.3 Development History

2. Global Dialysis Market
2.1 Morbidity of Chronic Renal Failure
2.2 Dialysis Product Market
2.3 Treatment Cost

3. Status Quo of China's Dialysis Market
3.1 Development Status
3.2 Policy Environment
3.2.1 Medical Insurance Leans to Uremia, the Reimbursement Proportion Was Raised
3.2.2 Introduction of Hemodialysis Industrial Standard
3.2.3 Related Peritoneal Dialysis Policies
3.3 Favorable Factors
3.4 Existing Problems
3.4.1 Excessive Government Regulation Increases the Treatment Costs
3.4.2 Medical Market Access Was Limited; Large-scale Hospitals Monopolize Hemodialysis Equipments; It is Difficult to Form Price Competition
3.4.3 Family Hemodialysis is Restricted by Policy, Reimbursement and Some Other Issues

4. Overview of Subdivided Industries
4.1 Dialyzer
4.2 Dialysis Machine
4.3 Hemodialysis Solutions

5. Import and Export of Dialysis Equipments
5.1 Import
5.2 Export

6. Key Overseas Production Enterprises
6.1 Fresenius (Germany)
6.1.1 Company Profile
6.1.2 Business Development
6.1.3 Business Performance
6.1.4 Business in China
6.1.5 Outlook
6.2 Nikkiso (Japan)
6.2.1 Company Profile
6.2.2 Main Products
6.2.3 Business Performance
6.3 Baxter (the United States)
6.3.1 Company Profile
6.3.2 Operation Status
6.3.3 Renal Dialysis Business
6.3.4 Operation in China
6.4 Asahi Kasei (Japan)
6.4.1 Company Profile
6.4.2 Operation Status of Medical Care Department
6.4.3 Operation in China
6.4.4 Development Strategy and Goal
6.5 B.Braun (Germany)
6.5.1 Company Profile
6.5.2 Operation Status
6.5.3 Dialysis Department
6.5.4 Business in China
6.6 NxStage (the United States)
6.6.1 Company Profile
6.6.2 Operation Status
6.6.3 Portable Hemodialysis Machine Business
6.6.4 Hemodialysis Consumable Business
6.7 Gambro (Sweden)
6.7.1 Company Profile
6.7.2 Operation Status
6.7.3 Business in China

7. Key Domestic Production Enterprises
7.1 Weigao Group
7.1.1 Company Profile
7.1.2 Dialysis Products
7.1.3 Channel Development
7.1.4 Hemodialysis Business
7.1.5 Peritoneal Dialysis Business
7.2 Huaren Pharmaceutical Co., Ltd.
7.2.1 Company Profile
7.2.2 Operation Status
7.2.3 Peritoneal Dialysis Business
7.2.4 R&D and Marketing of New Products
7.2.5 Business Plan in 2013
7.3 Boxlight
7.3.1 Company Profile
7.3.2 Operation Status
7.3.3 Hemodialysis Business
7.3.4 Development of New Hemodialysis Equipments
7.3.5 Development Plan of Hemodialysis Channel
7.4 Kelun Pharmaceutical
7.4.1 Company Profile
7.4.2 Main Products
7.4.3 Operation Status
7.4.4 Peritoneal Dialysis Business
7.4.5 Development Strategy
7.5 Jihua Medical Apparatus and Instruments Co., Ltd.
7.5.1 Company Profile
7.5.2 Product Research and Development
7.5.3 Hemodialysis Business
7.5.4 SWOT
7.5.5 Development Strategy
7.6 Bain Medical Equipment Co., Ltd.
7.6.1 Company Profile
7.6.2 Competitive Advantages
7.6.3 Development Planning
7.7 Jiangsu Lengthen Life Science and Technology Co., Ltd.
7.7.1 Company Profile
7.7.2 Production and Operation Status
7.7.3 Development Strategy
7.8 Guangzhou Koncen Biotechnology Co., Ltd.
7.8.1 Company Profile
7.8.2 Production and Operation Status
7.8.3 Development Planning

8. Investment Analysis and Suggestions of China's Dialysis Industry
8.1 Development Prospect
8.2 Investment Opportunity
8.3 Suggestions from Industrial Experts
8.3.1 Vigorously Develop Small-scale Portable Equipments
8.3.2 Ensure the Medical Safety through Strict Standardized Training
8.3.3 Complete Family Hemodialysis Related Reimbursement Policies
8.3.4 Open the Market Access; Allow Private Capital to Establish Hemodialysis Center; Standardize Related Detailed Rules
8.3.5 Make Use of Price and Geographical Advantages; Actively Explore the Southeast Asian Markets

For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441
Website: http://www.rnrmarketresearch.com